神经母细胞瘤的治疗进展

摘要

神经母细胞瘤是儿童期比较常见的恶性实体肿瘤,发病时临床表现多种多样,初期诊断具有一定困难性,且易发生早期转移,是引起儿童期死亡的主要疾病之一,高危神经母细胞瘤患儿的临床治疗效果仍具有很大挑战性.目前神经母细胞瘤的治疗方法主要集中在手术治疗、系统化疗、放射治疗、移植技术等.近年来更着重于靶向治疗及分子生物学(即基因学)治疗上的研究.靶向治疗是靶向性地与肿瘤的不同特异性位点发生作用,从而杀死肿瘤细胞,减少对正常组织的影响,为神经母细胞瘤患儿提供更加安全有效的治疗方案.%Neuroblastoma (NB)is a common malignant solid tumor in childhood,which has various clinical manifestations.It is difficult to diagnose and to prone to early metastasis.It is one of the main diseases causing death in childhood.The treatment of children with high-risk NB is still very challenging.At present,the treatments of NB mainly concentrated in the surgery,chemotherapy,radiation therapy and transplantation technology,etc.In recent years,more studies focus on targeted therapy and molecular biology (genetics) treatment.Targeted therapy is targeted to different specific loci of tumor,so as to kill tumor cells and reduce the impact on the normal tissue,which supplies more safe and effective treatments for children with NB.